Pharma & Biotech

Ionis Pharmaceuticals is experiencing a dramatic upward trajectory, with its stock performance capturing significant market attention. The biotech firm's impressive...

Absci finds itself navigating turbulent financial waters as the biotechnology firm grapples with plunging revenue alongside aggressive investment in its...

Investors in Akero Therapeutics are bracing for a pivotal moment as the biopharmaceutical company approaches a decisive regulatory deadline. With...

While numerous biotechnology firms are scaling back expectations, Supernus Pharmaceuticals is projecting a surprisingly confident stance by reaffirming its annual...

Biotechnology firm Equillium is executing a profound strategic overhaul, pivoting its entire operational focus to a single, promising drug candidate....

For Replimune and its investors, 2026 is shaping up to be a defining period. After a significant regulatory setback in...

While Redcare Pharmacy shares continue their prolonged decline, having shed more than 60% from their December peak, a significant development...

The battle for dominance in the lucrative weight-loss medication sector has entered a new phase of competition. Novo Nordisk, the...

The fate of German biotech firm CureVac hangs in the balance as shareholders prepare for a landmark decision that could...

Johnson & Johnson's equity is demonstrating remarkable momentum, advancing for five consecutive trading sessions with a notable surge in volume...